The market for unborn children: Big Pharma, vaccines and trafficking of aborted fetuses

American family clinics, such as the Planned Parenthood Institute, first help women stop pregnancy . And immediately after, with half-closed doors, a very profitable journey begins. The aborted fetus is dissected in different parts, liver, kidney, thyme, skin, which are sold. A liver can cost up to $ 350. I n a video shot “undercover” within Planned Parenthood by the pro life Center for Medical Progress organization, the price list of the company Da Vinci Biosciences , a fetal tissue brokerage firm , also appears : $ 750 for the brain of the fetus, 500 for the lymphatic glands, 350 for a kidney.

Spotlight

UQUIFA

Uquifa is the API division of Vivimed Labs. Uquifa is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical Industry. Operates 3 manufacturing sites, 2 in Spain and 1 in Mexico, which operates under cGMP conditions and has been inspected and approved by major Pharmaceutical Companies and Regulatory Authorities, including the US FDA.

OTHER ARTICLES
Pharma Tech

How long will the world wait for the next pandemic of antimicrobial resistance before we act?

Article | August 9, 2022

Antimicrobial resistance (AMR) has become an increasingly serious global health problem in recent years. World Health Organization (WHO) estimates that more than 700,000 people die each year due to drug-resistant infections, and the number is expected to increase in the coming years. How does antimicrobial resistance emerge? Antimicrobial resistance (AMR) occurs when bacteria, viruses, fungi, and parasites change over time and no longer respond to medicines. It makes infections harder to treat and increases the risk of disease, severe illness, and death. When we use antibiotics, some bacteria die, but resistant bacteria can survive and even multiply. The overuse of antibiotics and substandard antibiotics make resistant bacteria more common. So, the more we use antibiotics, the more chances bacteria have to become resistant to them. The rise in AMR is caused by multiple factors including the misuse and overuse of antibiotics by humans as well as in livestock and agriculture. Although these are the main drivers in the development of drug-resistant pathogens, the emergence of substandard and falsified antibiotics is another lesser-known, huge contributory factor. Even though AMR is a leading cause of death around the world, it is tracked most closely in clinical high-income settings and developed countries. Unfortunately, this is not the case in low and middle-income countries, where the highest burden is in low-resource settings and low-and middle-income countries (LMICs). These countries are disproportionately affected, in part due to the high burden of communicable diseases. Consequences to human health of AMR AMR poses significant risks to human health, resulting in prolonged and more severe infections, extended hospitalizations, and increased healthcare expenses. It can also lead to an increased risk of death, as an infection may become untreatable. Additionally, it can reduce the effectiveness of medicines and treatments, making it more difficult to manage existing medical conditions. It is even more concerning that it can lead to the emergence of new, more dangerous strains of bacteria, viruses, and other microbes. This would mean medical procedures, such as surgery, including caesarean sections or hip replacements, cancer chemotherapy, and organ transplantation, will become riskier. Counterfeit medicines and antibiotics: Antibiotics are the most counterfeited medicines in the world, as they account for 28% of global counterfeit medicines. Substandard and falsified antibiotics are medicines that do not meet the quality standards set by regulatory authorities. Counterfeit antibiotics are estimated at 5% of the global antibiotic market. These medicines are often of inferior quality or contain incorrect ingredients or incorrect amounts of active ingredients. They may also contain toxic contaminants or be expired, posing serious consequences for patients. Sadly, counterfeit antibiotics are mostly found in LMICs due to a lack of regulation and enforcement, as well as a lack of access to quality healthcare. In many of these countries, the demand for antibiotics is higher than the supply, and counterfeit antibiotics are seen as a cheaper and more accessible alternative. Furthermore, there is a lack of awareness around the dangers of taking counterfeit antibiotics, and there is a lack of resources for health authorities to test for the authenticity of these medicines. Why are antibiotics so rife for counterfeit drugs? Counterfeiters of pharmaceuticals succeed in large part by exploiting weaknesses in supply chains, which are often fragmented with poor regulatory frameworks. Antibiotics are often counterfeited because they are in high demand and can be sold for a large profit. To combat the problem of substandard and falsified antibiotics, governments must take a multi-pronged approach. This should encompass enacting laws and regulations to ensure the quality and safety of medicines, conducting surveillance for detecting and removing substandard and falsified products from the market, as well as providing training and education to healthcare professionals and patients regarding the responsible use of antibiotics. In addition, governments must work to strengthen the pharmaceutical supply chain. This includes increasing the transparency of the supply chain, improving the quality control systems, and introducing traceability systems to track the movement of medicines from the manufacturer to the patient. Medical investment in low and middle-income countries Another neglected aspect by international NGOs and governments is investment in building local laboratory capacity in LMICs to combat antimicrobial resistance. Localized laboratory facilities can help identify, track, and prevent the spread of antimicrobial-resistant infections, as well as provide early warnings of emerging drug-resistant strains. Localized microbiology, surveillance, and quality control laboratories can also play an important role in developing new treatments and interventions for combating antimicrobial resistance. In addition, having localized laboratory capacity can provide more accurate standardized data on the prevalence of drug-resistant infections, which can help inform policy decisions and public health interventions. Affordable medicines Finally, governments must work to increase access to high-quality, affordable medicines. This includes improving the availability of generic medicines, which are typically cheaper alternatives to brand-name drugs. They also need to increase access to newer, more effective antibiotics.

Read More
PHARMACY MARKET

Tips for Managing Chronic Pain Beyond Prescription Painkillers

Article | October 10, 2023

Painkillers like Oxycontin, Percocet, and Vicodin, have been prescribed by primary physicians, surgeons, dentists, and other healthcare providers to patients suffering from varying levels of pain. Though these medications have proven to be an effective source of pain relief, they have also proven to be highly addictive. In fact, it has even been reported that there are more cases of a drug overdose and deaths from prescription painkillers than heroin or cocaine. While there are a number of factors that play into this opioid epidemic, educating doctors and patients on alternative solutions to managing chronic pain is a great place to start combatting this nationwide crisis.

Read More
Pharma Tech

What are the advantages of PCD Pharma Company?

Article | July 13, 2022

PCD Pharma stands for propaganda distribution. A PCD company gives brand name and support to its franchises. They also provide distribution rights and monopoly rights within a particular region. If a person wants to establish their business, it is a must for them to know the pros and cons of the business to make a sound decision. Needless to mention that PCD company has a lot to contribute in the medical filed. Worldwide in a medical field, A PCD Pharma Company is playing an essential and crucial role in the rapid growth. The pharma industry is progressing t a fast pace. The company uses the latest technologies for each brand which ensures the safety of products and accepts the responsibility of human health & life by providing better outcomes. To have a drug license number and company registration, the cost to establish the company is quite cost-effective that is15000-20000rs. So this gives people a brilliant opportunity to have their unit without digging a big hole in their bank balance. Indian produces exquisite quality products, which make pharma companies a considerable success.

Read More

WALGREEN’S IN HOT WATER OVER PHONY PHARMACIST

Article | February 11, 2020

The drugstore chain agreed to pay $7.5 million in fines after an unlicensed pharmacist at several San Francisco Bay locations illegally filled more than 700,000 prescriptions over a ten-year period. According to California prosecutors, Kim Thien Le stole license numbers from other pharmacists to fill prescriptions for Fentanyl, morphine, and other painkillers. Le pleaded guilty to multiple felony impersonation counts. Walgreen’s agreed to the settlement to avoid being charged with consumer fraud in Alameda and Santa Anna Counties. Prosecutors alleged that Walgreen’s failed to verify Le’s license and did not conduct a thorough background check. The company insisted it has taken remedial measures.

Read More

Spotlight

UQUIFA

Uquifa is the API division of Vivimed Labs. Uquifa is a manufacturer of Active Pharmaceutical Ingredients (APIs) and intermediates for the pharmaceutical Industry. Operates 3 manufacturing sites, 2 in Spain and 1 in Mexico, which operates under cGMP conditions and has been inspected and approved by major Pharmaceutical Companies and Regulatory Authorities, including the US FDA.

Related News

In the World of Big Pharma, an Italian Oral Spray Survives

Dr ZinX | July 10, 2020

Yonah S. Tehrani, MD on the potential benefit of the Dr ZinX Zinc + Hinokitiol combination: "The antiviral effects and benefits of Zinc and Hinokitiol may have a tremendous impact on affected individuals and health care systems worldwide." Zinc is a mineral of critical importance to the proper functioning of the immune system in all age groups. Zinc deficiency may result in low resistance to viruses and bacteria. Studies dating back to 1974 have shown that zinc supplementation may contribute to faster recovery from viral illness by directly inhibiting viral replication at the protein level. In order for Zinc to cross into our cells and operate a special transport system is required. This system includes zinc ionophores and zinc binding-proteins. The list of zinc ionophores is extensive and includes Hinokitiol, hydroxychloroquine, quercetin, epigallocatechin, pyrithione, zincophorin, and others.

Read More

Big Pharma game heading for console release next month

pharmaphorum | November 19, 2019

First launched as a PC game in 2015, Big Pharma will be available for all three major games consoles – Sony’s PlayStation 4, Nintendo Switch, and Microsoft Xbox One – from next month, according to publisher Klabater. The game – developed by Twice Circled and Positech Games – is described as “part business sim, part logistics puzzle,” and puts players in the hot seat of a biopharma start-up, trying to translate R&D discoveries into blockbuster brands and transform the company into a multinational corporation. Players start with an empty warehouse, and have to buy the equipment and technology to try to turn it into a profitable factory with multiple production lines, whilst also pumping cash into R&D and sending drug-hunting explorers around the world. The game includes a number of challenges and quests to test budding CEOs as they try to build their empire, and discover whether their business approach is closer to disgraced ‘pharma bro’ Martin Shkreli – currently incarcerated – or legendary biotech pioneer Henri Termeer.

Read More

Cork County on the Rise: Big pharma feels at home in Cork

Irish Examiner | November 14, 2019

In 1969, when global biopharmaceutical company Pfizer located in Ringaskiddy, Cork was a very different place. Verolme, the Dutch-owned shipyard in Rushbrooke, was busy making ships, some of them patrol and fisheries vessels for the State. For generations, workers at the Sunbeam factory in Blackpool had been making textiles. On the banks of the Lee, Ford, or Ford’s as it was known locally, operated an assembly plant that made cars and tractors for places as far away as Argentina. If they needed tyres, Dunlop was only down the road. In the 50 years since, all of these companies have disappeared except Pfizer. Ringaskiddy was Pfizer’s first Irish location. Since then, the company has expanded to six sites in the country, including in Little Island. From an initial investment of €10m in 1969, Pfizer’s investment in Ireland is now €8bn, with a €2bn contribution annually to the economy. Pfizer has a 3,700-strong workforce, making it one of the country’s largest employers.

Read More

In the World of Big Pharma, an Italian Oral Spray Survives

Dr ZinX | July 10, 2020

Yonah S. Tehrani, MD on the potential benefit of the Dr ZinX Zinc + Hinokitiol combination: "The antiviral effects and benefits of Zinc and Hinokitiol may have a tremendous impact on affected individuals and health care systems worldwide." Zinc is a mineral of critical importance to the proper functioning of the immune system in all age groups. Zinc deficiency may result in low resistance to viruses and bacteria. Studies dating back to 1974 have shown that zinc supplementation may contribute to faster recovery from viral illness by directly inhibiting viral replication at the protein level. In order for Zinc to cross into our cells and operate a special transport system is required. This system includes zinc ionophores and zinc binding-proteins. The list of zinc ionophores is extensive and includes Hinokitiol, hydroxychloroquine, quercetin, epigallocatechin, pyrithione, zincophorin, and others.

Read More

Big Pharma game heading for console release next month

pharmaphorum | November 19, 2019

First launched as a PC game in 2015, Big Pharma will be available for all three major games consoles – Sony’s PlayStation 4, Nintendo Switch, and Microsoft Xbox One – from next month, according to publisher Klabater. The game – developed by Twice Circled and Positech Games – is described as “part business sim, part logistics puzzle,” and puts players in the hot seat of a biopharma start-up, trying to translate R&D discoveries into blockbuster brands and transform the company into a multinational corporation. Players start with an empty warehouse, and have to buy the equipment and technology to try to turn it into a profitable factory with multiple production lines, whilst also pumping cash into R&D and sending drug-hunting explorers around the world. The game includes a number of challenges and quests to test budding CEOs as they try to build their empire, and discover whether their business approach is closer to disgraced ‘pharma bro’ Martin Shkreli – currently incarcerated – or legendary biotech pioneer Henri Termeer.

Read More

Cork County on the Rise: Big pharma feels at home in Cork

Irish Examiner | November 14, 2019

In 1969, when global biopharmaceutical company Pfizer located in Ringaskiddy, Cork was a very different place. Verolme, the Dutch-owned shipyard in Rushbrooke, was busy making ships, some of them patrol and fisheries vessels for the State. For generations, workers at the Sunbeam factory in Blackpool had been making textiles. On the banks of the Lee, Ford, or Ford’s as it was known locally, operated an assembly plant that made cars and tractors for places as far away as Argentina. If they needed tyres, Dunlop was only down the road. In the 50 years since, all of these companies have disappeared except Pfizer. Ringaskiddy was Pfizer’s first Irish location. Since then, the company has expanded to six sites in the country, including in Little Island. From an initial investment of €10m in 1969, Pfizer’s investment in Ireland is now €8bn, with a €2bn contribution annually to the economy. Pfizer has a 3,700-strong workforce, making it one of the country’s largest employers.

Read More

Events